Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-25 | "We believe Mr. Hastings' qualifications to sit on our board of directors include his financial expertise and his extensive experience in the pharmaceutical and biotechnology industries." |
| 2014-04-22 | "Mr. Hastings has been the president and chief executive officer... of OncoMed Pharmaceuticals, Inc." |
| 2015-04-21 | "Mr. Hastings has been the president and chief executive officer... of OncoMed Pharmaceuticals..." |
| 2016-04-21 | "Mr. Hastings has been the president and chief executive officer ... of OncoMed Pharmaceuticals... Prior to joining OncoMed, Mr. Hastings was president and chief executive officer of QLT, Inc.... He received a Bachelor of Science degree in pharmacy from the University of Rhode Island." |
| 2017-04-21 | "Mr. Hastings has been the President and Chief Executive Officer... He received a Bachelor of Science degree in pharmacy from the University of Rhode Island." |
| 2018-04-27 | "Mr. Hastings has served as President and Chief Executive Officer of Nkarta Therapeutics... Prior to that... OncoMed Pharmaceuticals... QLT, Inc...." |
| 2019-04-22 | "He received a Bachelor of Science degree in pharmacy from the University of Rhode Island." |
| 2020-04-24 | "Mr. Hastings has served as President and Chief Executive Officer of Nkarta Therapeutics... Prior to that... OncoMed Pharmaceuticals... QLT, Inc.... He received a Bachelor of Science degree in pharmacy" |
| 2021-04-22 | “He received a Bachelor of Science degree in pharmacy from the University of Rhode Island.” |
| 2022-04-22 | “Paul Hastings ♦ Chief Executive Officer, Nkarta Therapeutics, Inc.” |
| 2023-04-21 | “Paul Hastings Chief Executive Officer, Nkarta Therapeutics, Inc.” |
| 2024-04-22 | “We believe Mr. Hastings’ qualifications to sit on our board include extensive experience in the pharmaceutical and biotechnology industries.” |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09